SARS-CoV-2 vaccines in development | Nature

SARS-CoV-2 vaccines in development | Nature

The SARS-CoV-2 vaccine landscape now

Virologist and vaccinologist Florian Krammer offers a comprehensive review of the SARS-CoV-2 vaccine landscape, including the status of the front-running candidates and their approaches. He also notes the enormous practical challenges and many unanswered questions, such as how long vaccine immunity will persist. The outlook is “cautiously positive”, writes Krammer. “It is certainly possible that vaccines with safety and efficacy proven in phase III trials might already enter the market in 2020.” Krammer’s epic 138-tweet thread spells it out in simpler terms.

Nature | 37 min read or Twitter thread